Christopher Downs, Chief Financial Officer at CNS Pharmaceuticals, Inc. (CNSP), bought 3,100 shares at $3.20 ($10K) on 2023-04-17, disclosed to the SEC on 2023-04-18.
Open-market purchase of $10k CNSP by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CNSP | BUY | 2021-12-07 | $5K | — | Filing → |
| CNSP | BUY | 2021-11-22 | $5K | — | Filing → |
| CNSP | BUY | 2020-08-25 | $290K | — | Filing → |